Recent Updates
Recently added Catalysts
ORMP Positive Sentiment Score: 75/100

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit

Thursday, May 18, 2023 1 min read
Key Takeaway: Oramed Pharmaceuticals has announced that its Chief Scientific Officer, Dr. Miriam Kidron, will present at the Novel Therapies for Type 2 Diabetes & Obesity Summit in Boston on May 31, 2023. The presentation will include an overview of the company's oral delivery technology and findings from its recent Phase 3 oral insulin clinical trials. This event marks an important opportunity for Oramed to showcase its advancements in drug delivery solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Oramed's Chief Scientific Officer will present at a prominent summit.
  • The presentation will highlight innovative oral delivery technology.
  • Insights from recent Phase 3 clinical trials are expected.

Full Press Release Details

NEW YORK, May 18, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), announced today that Chief Scientific Officer Dr. Miriam Kidron will deliver an in-person presentation at the Novel Therapies for Type 2 Diabetes & Obesity Summit in Boston, MA, on May 31, 2023. The presentation will include an overview of Oramed's oral delivery technology as well as insights from the Company's recent Phase 3 oral insulin clinical trials.
Presentation Details:
Novel Therapies for Type 2 Diabetes & Obesity Summit
Date: Wednesday, May 31, 2023
Time: 1:30 p.m. E.T.
Location: Hyatt Regency Boston, Boston, MA
For more information regarding the summit and the presentation, please visit the Summit's website: Home - Novel Therapies for Type 2 Diabetes & Obesity Summit 2023 (t2d-obesity-summit.com)
About Oramed Pharmaceuticals
Oramed Pharmaceuticals (Nasdaq/TASE: ORMP) is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. The Company's novel Protein Oral Delivery (POD™) technology is designed to protect drug integrity and increase absorption. Oramed has offices in the United States and Israel. For more information, please visit www.oramed.com.
Logo - https://mma.prnewswire.com/media/1724339/Oramed_Logo.jpg
SOURCE Oramed Pharmaceuticals Inc.

21 %

more press release views with

Frequently Asked Questions

When is Oramed's presentation at the summit?

Oramed's presentation is on May 31, 2023.

Who will present at the Type 2 Diabetes summit?

Dr. Miriam Kidron, Oramed's Chief Scientific Officer, will present.

Where is the summit being held?

The summit is at the Hyatt Regency Boston, MA.

What will Oramed's presentation cover?

It will cover oral delivery technology and Phase 3 clinical trial insights.

What technology does Oramed specialize in?

Oramed specializes in oral delivery solutions for injectable drugs.

Tags: ORMP Viatris Investor Conferences Healthcare Oramed Type 2 Diabetes obesity oral insulin clinical trials
Last updated: May 18, 2023